Journal of Nutrition and Health

The Korean Nutrition Society (한국영양학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of xylobiose-sugar mixture on defecation frequency and symptoms in young women with constipation

자일로바이오스를 함유한 설탕이 젊은 여성의 변비 개선에 미치는 효과

  • 이정숙 (국민대학교 식품영양학과) ;
  • 김아름 (국민대학교 식품영양학과) ;
  • 남혜경 (국민대학교 식품영양학과) ;
  • 경명옥 (대한제당(주) 중앙연구소) ;
  • 조성은 (대한제당(주) 중앙연구소) ;
  • 장문정 (국민대학교 식품영양학과)
  • Received : 2016.12.20
  • Accepted : 2017.02.06
  • Published : 2017.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The objective of the study was to investigate the effects of xylobiose-sugar mixture intake on defecation frequency and constipation symptoms in 31 young women with constipation. Methods: Thirty-one subjects were assigned to two groups, and subjects in each group were administered 10 g of a 7% xylobiose-sugar mixture (Experiment 1: XBS, n = 15) or 10 g of a 7% xylobiose-sugar mixture containing coffee mix (Experiment 2: XBS coffee mix, n = 16) twice per day for 6 weeks. During the study, clinical efficacy was assessed by a daily diary record. The subjects recorded their defecation frequency and fecal characteristics. Results: During pretreatment week, mean defecation frequency of XBS subjects was 2.13 times/week, whereas that of XBS coffee mix subjects was 1.56 times/week. The mean defecation frequencies of XBS and XBS coffee mix subjects increased significantly to 3.73 times/week (p < 0.05) and 3.56 times/week by week 6 (p < 0.05), respectively. After treatment with either XBS or XBS coffee mix, patients presented significant improvements in their amounts of stool, feelings of residual stool leftness, and abdominal pain symptoms (p < 0.05). The total constipation scoring system (CSS) for diagnosing constipation symptoms significantly decreased in the XBS group (10.53 score vs 7.22 score) and in the XBS coffee mix group (10.75 score vs 6.51 score) after 6 weeks. Improvement due to intake of 7% xylobiose-containing sugar seemed to last during the experimental period. Conclusion: The addition of approximately 7% xylobiose to commercially available sweeteners has been shown to improve constipation.

본 연구는 자일로바이오스 함유 설탕 섭취가 젊은 여성의 변비 개선효과를 확인하기 위해 실시하였다. 20~29세 여성 31명을 대상을 이중맹검법을 적용하여 7% 자일로바이오스 함유 설탕 시료 (XBS, n = 15)와 7% 자일바이오스 함유 설탕을 포함한 커피믹스 시료 (XBS coffee mix, n = 16)를 1일 2회씩 6주간 섭취하도록 하였다. 시료 섭취 결과 배변 횟수는 시료 섭취 전 XBS 2.13회/주, XBS coffee mix 1.56회/주에서 시료 섭취 1주차부터 증가하여 시료 섭취 6주차에는 각각 3.73회, 3.56회로 증가하였다. 또한 XBS와 XBS coffee mix 시료 모두 섭취 후 배변의 양, 복부 잔변감, 복통의 증상이 유의적으로 개선되었고, 변비의 상태를 진단할 수 있는 CSS 점수 역시 시료 섭취 전 XBS 10.53점, XBS coffee mix 10.75점에서 시료 섭취 후 1주차부터 유의적으로 감소하였고, 시료 섭취 6주차에 XBS 7.22점, XBS coffee mix 6.51점으로 3점 이상 낮아졌다. 즉, 시료 섭취 전에 비해 시료 섭취 후 유의적으로 CSS 점수가 낮아진 것으로 보아 7% 자일로바이오스 함유 설탕 섭취가 변비를 지속적으로 개선하는 효과가 있는 것으로 판단된다. 본 연구는 설문조사 방법을 통해서 배변 및 변의 상태를 평가한 것으로 화학적 지표성분 변화에 대한 평가를 수행하지 않았다는 한계는 존재하나 설탕보완재 역할을 지닌 자일로바이오스를 7% 정도 설탕에 첨가할 경우 변비를 개선하는 효과가 있는 것으로 나타나고 있으므로 시판되는 다양한 종류의 가공식품에 기능성 감미료로서의 활용이 가능할 것으로 사료된다.

Keywords

References

  1. American College of Gastroenterology Chronic Constipation Task Force. An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol 2005; 100 Suppl 1: S1-S4. https://doi.org/10.1111/j.1572-0241.2005.50613_1.x
  2. Johanson JF, Kralstein J. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther 2007; 25(5): 599-608. https://doi.org/10.1111/j.1365-2036.2006.03238.x
  3. Myung SJ, Lee TH, Huh KC, Choi SC, Sohn CI; Korean Society of Neurogastroenterology and Motility. Diagnosis of constipation: a systematic review. Korean J Gastroenterol 2010; 55(5): 316-324. https://doi.org/10.4166/kjg.2010.55.5.316
  4. Talley NJ, Fleming KC, Evans JM, O'Keefe EA, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol 1996; 91(1): 19-25.
  5. Jung HS, Song YM, Lee JK, Kim YW, Han SH, Kang SC, Kim YE. Lifestyle factors related to constipation in working women. J Korean Acad Fam Med 2002; 23(9): 1124-1132.
  6. Shin JE, Jung HK, Lee TH, Jo Y, Lee H, Song KH, Hong SN, Lim HC, Lee SJ, Chung SS, Lee JS, Rhee PL, Lee KJ, Choi SC, Shin ES; The Clinical Management Guideline Group under the Korean Society of Neurogastroenterology and Motility. Guidelines for the diagnosis and treatment of chronic functional constipation in Korea, 2015 revised edition. Korean J Med 2016; 91(2): 114-130. https://doi.org/10.3904/kjm.2016.91.2.114
  7. Childs CE, Roytio H, Alhoniemi E, Fekete AA, Forssten SD, Hudjec N, Lim YN, Steger CJ, Yaqoob P, Tuohy KM, Rastall RA, Ouwehand AC, Gibson GR. Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study. Br J Nutr 2014; 111(11): 1945-1956. https://doi.org/10.1017/S0007114513004261
  8. Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004; 17(2): 259-275. https://doi.org/10.1079/NRR200479
  9. Hsu CK, Liao JW, Chung YC, Hsieh CP, Chan YC. Xylooligosaccharides and fructooligosaccharides affect the intestinal microbiota and precancerous colonic lesion development in rats. J Nutr 2004; 134(6): 1523-1528. https://doi.org/10.1093/jn/134.6.1523
  10. Rycroft CE, Jones MR, Gibson GR, Rastall RA. A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol 2001; 91(5): 878-887. https://doi.org/10.1046/j.1365-2672.2001.01446.x
  11. Rolston DD, Mathan VI. Xylose transport in the human jejunum. Dig Dis Sci 1989; 34(4): 553-558. https://doi.org/10.1007/BF01536332
  12. Korea Food & Drug Administration. Xylooligosaccharide. Seoul: Korea Food & Drug Administration; 2009.
  13. Akpinar O, Erdogan K, Bostanci S. Enzymatic production of xylooligosaccharide from selected agricultural wastes. Food Bioprod Process 2009; 87(2): 145-151. https://doi.org/10.1016/j.fbp.2008.09.002
  14. Okazaki M, Koda H, Izumi R, Fujikawa S, Matsumoto N. In vitro digestibility and in vivo utilization of xylobiose. J Jpn Soc Nutr Food Sci 1991; 44(1): 41-44. https://doi.org/10.4327/jsnfs.44.41
  15. Vazquez MJ, Alonso JL, Dominguez H, Parajo JC. Xylooligosaccharides: manufacture and applications. Trends Food Sci Technol 2000; 11(11): 387-393. https://doi.org/10.1016/S0924-2244(01)00031-0
  16. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004; 79(4): 537-543. https://doi.org/10.1093/ajcn/79.4.537
  17. Korea Health Industry Development Institute; Ministry of Food and Drug Safety (KR). Sugar database compilation for commonly consumed foods. Cheongju: Korea Health Industry Development Institute; 2015.
  18. Korea Consumer Agency. A report on the comparison of the component of coffee mixtures [Internet]. Seoul: Korea Consumer Agency; 2014 [cited 2015 Oct 10]. Available from:http://www.kca.go.kr/brd/m_32/view.do?seq=1634&multi_itm_seq=0
  19. Shin HL. Consumer attitude survey: beverage purchasing behaviors and preferences [dissertation]. Seoul: Sejong University; 2010.
  20. Ministry of Agriculture, Food and Rural Affairs (KR); Korea Agro-Fisheries and Food Trade Corporation. 2015 processed food subdivision market status: beverage market. Sejong: Ministry of Agriculture, Food and Rural Affairs; 2015.
  21. Ministry of Health and Welfare (KR). Adequate intake of sugars per day. Sejong: Ministry of Health and Welfare; 2015.
  22. Drossman DA. Rome III: the new criteria. Chin J Dig Dis 2006; 7(4): 181-185. https://doi.org/10.1111/j.1443-9573.2006.00265.x
  23. Riegler G, Esposito I. Bristol scale stool form. A still valid help in medical practice and clinical research. Tech Coloproctol 2001; 5(3): 163-164. https://doi.org/10.1007/s101510100019
  24. Agachan F, Chen T, Pfeifer J, Reissman P, Wexner SD. A constipation scoring system to simplify evaluation and management of constipated patients. Dis Colon Rectum 1996; 39(6): 681-685. https://doi.org/10.1007/BF02056950
  25. Lee OS, Rhee IK. The production of xylooligosaccharides with microbial xylanase. Food Ind Nutr 2001; 6(1): 21-24.
  26. Jeon JH, Kyung M, Jung S, Jo S, Chang MJ. Effect of xylooligosaccharide-sugar mixture on defecation frequency and symptoms in young women with constipation: a randomized, double-blind, placebo-controlled trial. J Nutr Health 2015; 48(1): 19-29. https://doi.org/10.4163/jnh.2015.48.1.19
  27. Jung SJ, Chae SW, Sohn HS, Kim SB, Rho JO, Baik SH, Kang MH, Kim GH, Kim MH, Kim HS, Park EJ, Heo YR, Cha YS. Actual status of constipation and life factors affecting constipation by diagnosis of Rome in female university students in Korea. Korean J Nutr 2011; 44(5): 428-442. https://doi.org/10.4163/kjn.2011.44.5.428
  28. Preston DM, Lennard-Jones JE. Severe chronic constipation of young women: 'idiopathic slow transit constipation'. Gut 1986; 27(1): 41-48. https://doi.org/10.1136/gut.27.1.41
  29. Tateyama I, Hashii K, Johno I, Iino T, Hirai K, Suwa Y, Kiso Y. Effect of xylooligosaccharide intake on severe constipation in pregnant women. J Nutr Sci Vitaminol (Tokyo) 2005; 51(6): 445-448. https://doi.org/10.3177/jnsv.51.445
  30. Fujikawa S, Okazaki M, Matsumoto N, Koga K. Properties and production of xylooligosaccharide. J Jpn Soc Starch Sci 1990; 37(2): 69-77. https://doi.org/10.5458/jag1972.37.69
  31. Kobayashi T, Okazaki M, Fujikawa S, Koga K. Effect of xylooligosaccharides on feces of men. J Agric Chem Soc Jpn 1991; 65(11): 1651-1653.
  32. Na MH, Kim WK. Effects of xylooligosaccharide intake on fecal bifidobacteria, lactic acid and lipid metabolism in Korean young women. Korean J Nutr 2007; 40(2): 154-161.
  33. Kondo J, Xiao JZ, Shirahata A, Baba M, Abe A, Ogawa K, Shimoda T. Modulatory effects of Bifidobacterium longum BB536 on defecation in elderly patients receiving enteral feeding. World J Gastroenterol 2013; 19(14): 2162-2170. https://doi.org/10.3748/wjg.v19.i14.2162
  34. Campbell JM, Fahey GC Jr, Wolf BW. Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. J Nutr 1997; 127(1): 130-136. https://doi.org/10.1093/jn/127.1.130
  35. Zoppi G, Cinquetti M, Luciano A, Benini A, Muner A, Bertazzoni Minelli E. The intestinal ecosystem in chronic functional constipation. Acta Paediatr 1998; 87(8): 836-841. https://doi.org/10.1111/j.1651-2227.1998.tb01547.x
  36. Dimidi E, Christodoulides S, Fragkos KC, Scott SM, Whelan K. The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 2014; 100(4): 1075-1084. https://doi.org/10.3945/ajcn.114.089151
  37. Crittenden R, Karppinen S, Ojanen S, Tenkanen M, Fagerstrom R, Matto J, Saarela M, Fagerstrom R, Mattila-Sandholm T, Poutanen K. In vitro fermentation of cereal dietary fibre carbohydrates by probiotic and intestinal bacteria. J Sci Food Agric 2002; 82(8): 781-789. https://doi.org/10.1002/jsfa.1095
  38. Lee MR, Lee KA, Ly SY. Improving effects of fructooligosaccharide and isomaltooligosaccharide contained in sponge cakes on the constipation of female college students. J Korean Soc Food Sci Nutr 2003; 32(4): 621-626. https://doi.org/10.3746/jkfn.2003.32.4.621
  39. Lexicomp Inc. Magnesium oxide: drug information Lexicomp. Hudson (OH): Lexicomp Inc.; 2014.
  40. Wald A. Is chronic use of stimulant laxatives harmful to the colon? J Clin Gastroenterol 2003; 36(5): 386-389. https://doi.org/10.1097/00004836-200305000-00004
  41. Okazaki M, Koda H, Izumi R, Fujikawa S, Matsumoto N. In vitro digestibility and in vivo Utilization of Xyloiose. J J Soc Nutr Food Sci. 1991;44:41-44. https://doi.org/10.4327/jsnfs.44.41

Cited by

  1. 혈액 투석 환자의 변비 완화 및 생리적 지표 향상을 위한 융합형 미숫가루 음용 섭취 프로그램 개발 예비 조사 vol.9, pp.5, 2017, https://doi.org/10.22156/cs4smb.2019.9.5.040
  2. 참다래(키위)로 만든 제품의 장 기능 및 변비 개선에 미치는 효과 vol.21, pp.7, 2017, https://doi.org/10.5392/jkca.2021.21.07.650